Type I interferon response |
A276R |
Dampening type I IFN response by regulating IRF3 |
ND |
[163] |
Inflammatory response |
A528R |
Promoting the expression of ULK1 to degrade STING |
Attenuated |
[163] |
MGF360-12L |
Interacting with nuclear transport proteins importin α (KPNA2, KPNA3, and KPNA4) to disrupt NF-κB nuclear translocation |
ND |
[171] |
I329L |
Inhibiting the crucial adaptor protein TRIF |
ND |
[172] |
DP96R |
Degradation of TBK1 |
Attenuated |
[164] |
L83L |
No reduction in virulence |
No reduction in virulence |
[167] |
A238L |
Inhibiting the activation of the NF-κB pathway |
No reduction in virulence |
[161] |
Apoptosis |
226L, A151R, NP419L, QP383R |
ND |
ND |
[137] |
A179L |
Bind to pro-apoptotic proteins (Bid, Bim, Bak, and Bax) to inhibit apoptosis |
ND |
[104] |
A224L |
Activating NF-κB pathway to promote anti-apoptotic genes expression, e.g., IAP and Bcl-2 family proteins |
No reduction in virulence |
[173] |
EP153R |
Inhibiting the expression of caspase-3 |
ND |
[174] |
E183L |
Interacting with DLC8 to activate caspase-3 and caspase-9 |
ND |
[175] |
DP71L |
Recruit host phosphatase 1 (PP1) and remove the phosphorylation of eIF-2α to restore cellular protein synthesis to block CHOP activation suppressing apoptosis |
No reduction in virulence |
[176] |
A238L |
Inhibiting CaN to decrease apoptosis; NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation |
No reduction in virulence |
[177] |